Company
GermanyPublic company, NYSE: QGENQiagen GmbH (NYSE: QGEN), Hilden, Germany – FDA Inspections
Inspection records and compliance data for Qiagen GmbH in Hilden. 5 FDA inspections on record, last inspected March 12, 2026. Publicly traded as NYSE: QGEN.
Company Profile
This profile covers Qiagen GmbH based in Hilden, Germany.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 0
- VAI
- 1
- NAI
- 3
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected September 26, 2013. Last inspected March 12, 2026.
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 12, 2026 | Not classified | Medical Devices & Rad Health | 1314374 |
| November 4, 2022 | VAI | Medical Devices & Rad Health · Bioresearch Monitoring | 1197605 |
| February 9, 2017 | NAI | Medical Devices & Rad Health · Compliance: Devices | 1002815 |
| August 27, 2015 | NAI | Medical Devices & Rad Health · Bioresearch Monitoring | 945001 |
| September 26, 2013 | NAI | Medical Devices & Rad Health · Bioresearch Monitoring | 853200 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Qiagen GmbH
Stock ticker
QGEN
Exchange
NYSE
Share price
$50.87
Market cap
$10.5B
Price as of
November 6, 2026
FEI Number
3004013603
Address
Qiagen Str. 1, Hilden, Germany
Country
Germany
ID: ee8014e6-a226-4414-b52e-f5388c9834e3